Examkin

Question

Difficulty: Very hardDiagnostic Workup and Test Sequencing

A 36-year-old woman presents to the clinic with progressive weight gain, fatigue, and easy bruising over the past 8 months. She also reports irregular menstrual periods and new-onset facial hair growth. Blood pressure is 158/98 mmHg, pulse is 82/min, and BMI is 34 kg/m². Physical examination reveals facial plethora, prominent dorsocervical and supraclavicular fat pads, wide purple abdominal striae, and significant weakness when rising from a seated position. A baseline metabolic panel demonstrates a fasting blood glucose of 145 mg/dL and a serum potassium of 3.3 mEq/L. The physician suspects a specific endocrine disorder. Assuming positive or equivocal findings at each step that require further investigation, arrange the following diagnostic tests in the most appropriate chronological order to establish the diagnosis and definitive etiology, from initial screening to final preoperative localization.

  1. 1Overnight 1-mg dexamethasone suppression test
  2. 2Measurement of plasma adrenocorticotropic hormone (ACTH) concentration
  3. 3High-dose (8-mg) dexamethasone suppression test
  4. 4Magnetic resonance imaging (MRI) of the pituitary gland
  5. 5Bilateral inferior petrosal sinus sampling (IPSS)

Answer

The correct sequential order of diagnostic testing is: 1) Overnight 1-mg dexamethasone suppression test, 2) Measurement of plasma ACTH concentration, 3) High-dose (8-mg) dexamethasone suppression test, 4) Magnetic resonance imaging (MRI) of the pituitary gland, 5) Bilateral inferior petrosal sinus sampling (IPSS).
The diagnostic algorithm for Cushing syndrome is strictly hierarchical to prevent misdiagnosis. First, hypercortisolism is confirmed using an initial screening test (e.g., overnight low-dose dexamethasone suppression). Second, it is classified as ACTH-dependent or independent via plasma ACTH measurement. Third, ACTH-dependent sources are biochemically differentiated (e.g., using a high-dose dexamethasone suppression test). Fourth, the suspected anatomical location is imaged (Pituitary MRI). Finally, if imaging is equivocal or reveals a sub-6 mm adenoma, the source is confirmed invasively using bilateral inferior petrosal sinus sampling (IPSS).

Step-by-Step Solution

1
Confirm the presence of endogenous hypercortisolism.
Overnight 1-mg dexamethasone suppression test.
Before pursuing the etiology, excessive endogenous cortisol production must be definitively established.
2
Determine if the hypercortisolism is ACTH-dependent or ACTH-independent.
Measurement of plasma ACTH concentration.
A suppressed ACTH level indicates an adrenal source, whereas a normal or elevated ACTH level indicates a pituitary or ectopic source.
3
Differentiate between a pituitary and ectopic source of ACTH.
High-dose (8-mg) dexamethasone suppression test.
Pituitary adenomas typically retain some negative feedback regulation and will suppress cortisol production with high-dose dexamethasone, whereas ectopic tumors generally do not.
4
Localize the suspected pituitary adenoma anatomically.
Magnetic resonance imaging (MRI) of the pituitary gland.
Once biochemical tests suggest a pituitary source, MRI is performed to identify the adenoma for potential surgical resection.
5
Confirm the pituitary source if MRI is inconclusive or reveals a lesion smaller than 6 mm.
Bilateral inferior petrosal sinus sampling (IPSS).
IPSS is required to definitively prove central ACTH hypersecretion to avoid unnecessary pituitary surgery in a patient who may actually have an occult ectopic source, since small pituitary incidentalomas are relatively common.

Key Concept

Diagnostic sequencing for Cushing syndrome involves a strict hierarchy: confirming hypercortisolism, determining ACTH dependence, biochemically differentiating the ACTH source, imaging the localized region, and confirming anatomically ambiguous lesions via invasive venous sampling.
Rate this question

Topics

Diagnostic Workup and Test Sequencing

More questions from this topic